We are live on
!
Find out more
Walleye Capital Portfolio holdings
AUM
$24B
1-Year Est. Return
37.67%
This Fund
S&P 500
This Quarter
Est. Return
+34.77%
1 Year Est. Return
+37.67%
3 Year Est. Return
+98.01%
5 Year Est. Return
+160%
10 Year Est. Return
–
AUM
$1.54B
AUM Growth
-$138M
(-8.2%)
Cap. Flow
-$300M
Cap. Flow
% of AUM
-19.47%
Top 10 Holdings %
Top 10 Hldgs %
9.99%
Holding
2,498
New
653
Increased
404
Reduced
598
Closed
777
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CY
Cypress Semiconductor
CY
|
+$17M |
| 2 |
WBC
WABCO HOLDINGS INC.
WBC
|
+$15M |
| 3 |
ZAYO
Zayo Group Holdings, Inc.
ZAYO
|
+$14.8M |
| 4 |
MLNX
Mellanox Technologies, Ltd.
MLNX
|
+$11.6M |
| 5 |
CZR
Caesars Entertainment Corporation
CZR
|
+$11.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$2.77M |
| 2 |
Cigna
CI
|
+$2.57M |
| 3 |
Meta Platforms (Facebook)
META
|
+$2.48M |
| 4 |
Baidu
BIDU
|
+$2.2M |
| 5 |
Bausch Health
BHC
|
+$2.09M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 4.98% |
| 2 | Technology | 4.63% |
| 3 | Consumer Discretionary | 3.8% |
| 4 | Industrials | 1.77% |
| 5 | Financials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AMCIU
251
DELISTED
AMCI Acquisition Corp Unit
AMCIU
| $1.7M | 0.11% |
164,000
-1,000
| -0.6% | -$10.4K |
|
252
CALL
KB Home
KBH
$3.48B
| $1.7M | 0.11% |
49,600
-9,600
| -16% | -$332K |
|
253
CALL
Regeneron Pharmaceuticals
REGN
$68.8B
| $1.69M | 0.11% |
4,500
-30,900
| -87% | -$10.4M |
|
254
CALL
HCA Healthcare
HCA
$84.8B
| $1.69M | 0.11% |
11,400
+600
| +6% | +$80.6K |
|
|
ACHN
255
DELISTED
Achillion Pharmaceuticals
ACHN
| $1.68M | 0.11% |
+278,205
| New | +$1.61M |
|
256
CALL
PTC Therapeutics
PTCT
$6.37B
| $1.67M | 0.11% |
34,800
-7,600
| -18% | -$323K |
|
257
CALL
Molson Coors Class B
TAP
$7.68B
| $1.67M | 0.11% |
+31,000
| New | +$1.67M |
|
|
HYACU
258
DELISTED
Haymaker Acquisition Corp. II Unit
HYACU
| $1.67M | 0.11% |
159,000
-1,000
| -0.6% | -$10.4K |
|
259
PUT
Incyte
INCY
$23.5B
| $1.67M | 0.11% |
19,100
-23,700
| -55% | -$2.02M |
|
260
CALL
McKesson
MCK
$98.5B
| $1.66M | 0.11% |
+12,000
| New | +$1.7M |
|
261
CALL
Flex
FLEX
$43.4B
| $1.65M | 0.11% |
173,970
+162,292
| +1,390% | +$1.4M |
|
|
BOLD
262
DELISTED
Audentes Therapeutics, Inc
BOLD
| $1.63M | 0.11% |
+27,310
| New | +$1.02M |
|
|
OSG
263
Octave Specialty Group
OSG
$252M
| $1.63M | 0.11% |
+75,702
| New | +$1.55M |
|
264
McDonald's
MCD
$188B
| $1.6M | 0.1% |
+8,124
| New | +$1.61M |
|
265
CALL
Halliburton
HAL
$27.9B
| $1.6M | 0.1% |
65,400
-48,400
| -43% | -$1.02M |
|
266
CALL
Floor & Decor
FND
$5.81B
| $1.59M | 0.1% |
31,400
+14,900
| +90% | +$698K |
|
|
DO
267
CALL
DELISTED
Diamond Offshore Drilling
DO
| $1.59M | 0.1% |
221,600
+29,700
| +15% | +$173K |
|
268
CALL
Chemours
CC
$2.59B
| $1.59M | 0.1% |
88,000
-47,600
| -35% | -$791K |
|
269
CALL
MongoDB
MDB
$24B
| $1.59M | 0.1% |
12,100
+1,800
| +17% | +$236K |
|
270
CALL
AngloGold Ashanti
AU
$40.3B
| $1.59M | 0.1% |
71,200
-33,400
| -32% | -$672K |
|
|
FTCH
271
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
| $1.59M | 0.1% |
+153,621
| New | +$1.38M |
|
272
CALL
Jazz Pharmaceuticals
JAZZ
$15.9B
| $1.58M | 0.1% |
10,600
-73,400
| -87% | -$9.99M |
|
|
EXAS
273
PUT
DELISTED
Exact Sciences
EXAS
| $1.57M | 0.1% |
17,000
+10,600
| +166% | +$932K |
|
274
CALL
United Therapeutics
UTHR
$26.3B
| $1.56M | 0.1% |
17,700
-2,300
| -12% | -$202K |
|
275
CALL
Coca-Cola
KO
$354B
| $1.55M | 0.1% |
+28,100
| New | +$1.51M |
|
Similar funds
JG
SC
OAG
CS
Walleye Capital's Q4 2019 Portfolio in Review
As of Q4 2019, Walleye Capital held 2,498 positions worth $1.54B, down 8.2% from $1.68B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Walleye Capital withdrew a net $300M in Q4 2019, closing 777 positions and reducing 598 holdings. Its most notable exit was Cigna, an estimated $2.57M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 5% of assets, up from 1.9% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Walleye Capital opened a new position in Cypress Semiconductor worth $17M.
- Walleye Capital's largest Q4 2019 buy was Cypress Semiconductor: 727,918 shares worth $17M.
- Walleye Capital added most to Acacia Communications Inc in Q4 2019, an estimated $8.45M increase.
- Walleye Capital's biggest Q4 2019 reduction was Humana, cutting an estimated $2.77M.
- Walleye Capital fully exited Cigna in Q4 2019, selling an estimated $2.57M.
- Walleye Capital's ten largest holdings make up 10% of its $1.54B portfolio in Q4 2019.
- Walleye Capital opened 653 new positions and closed 777 in Q4 2019.
- Walleye Capital's portfolio value fell 8.2% quarter-over-quarter to $1.54B.
Based on Walleye Capital's 13F filing for Q4 2019, filed 14 Feb 2020.